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3 PUFAs, eicosapentaenoic acid (EPA) and docosahexaenoic acid @HA)] supplementation in the treatment of disorders involving an overreactive immune response, such as rheumatoid arthritis [see 1 for review]. Specific immune responses are initiated by the presentation of antigen to helper T-lymphocytes on the surface of an antigen-presenting cell (APC). A pre-requisite for this function of APCs is the cell surface expression of major histocompatibility complex (MHC) class I1 molecules (HLA-DR, -DP and -D Q , aided by the presence of adhesion molecules. It has been shown that the percentage of MHC class 11-positive monocytes and the density of these molecules on the cell surface can alter the degree of immune responsiveness of an individual [2] .
We have previously shown in vitro that EPA can inhibit the expression of the MHC class I1 molecule HLA-DR and of the adhesion molecule ICAM-1 on both unstimulated monocytes and on interferon-gamma (IFN-g) activated human monocytes [3] . In conaast, DHA increased the expression of these surface molecules on unstimulated monocytes, although it inhibited their expression on IFN-g stimulated cells in a similar manner to EPA [3] . In a dietary study, we observed a reduction in the relative number of HLA-DR and ICAM-1 molecules expressed on human peripheral blood monocytes following 3 weeks of fish oil supplementation [4] . Since most commercially available fish oil supplements contain a mixture of EPA and DHA, we undertook further in virro experiments to determine the combined effect of these n-3 PUFA on the cell surface expression of surface molecules involved in the process of antigen-presentation. In addition, the antigen-presenting function of monocytes, following incubation with or without n-3 PUFA, was assessed using tetanus toxoid as a challenge antigen.
Purified monocytes, obtained from healthy volunteers, were incubated with or without a mixture of EPA and DHA (final total concentration 20 pg/ml, combined at the same ratio as is commonly found in fish oil supplement capsules, ie. 2:l) in RPMI culture medium supplemented with 5% fetal calf serum for 48 h at 37'C. In addition, parallel cultures were performed in the presence of IFN-g (400 U/ml) to stimulate upregulation of MHC class I1 molecule expression by the monocytes. Abbreviations used: APC, antigen-presenting cell; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; IFN-g, interferon-gamma; MHC, major histocompatibility complex; ICAM-1, intercellular adhesion molecule-1; LFA, leucocyte function associated antigen; PUFA, polyunsaturated fatty acid. Following incubation, the monocytes were immunofluorescently stained with monoclonal antibodies raised against the MHC class I1 molecules (HLA-DR, -DP and -DQ, and the adhesion molecules ICAM-1, LFA-1 and LFA-3. Both the percentage of monocytes expressing each of these molecules and the intensity of expression of each molecule (ie. relative number per cell) was quantified by flow cytometry [5] .
To assess antigen-presenting function following incubation with the combined n-3 PUFA, in the presence of IFN-g, the monocytes were washed and incubated (3 h) with tetanus toxoid (25 Lf/ml; a kind gift from Medeva PLC) [ 5 ] . The monocytes were then cultured with autologous lymphocytes for a further 5 days before lymphocyte proliferation was quantified by ELISA (Boehringer Mannheim). Table 1 shows that in the presence of combined EPA+DHA, there was no significant difference in either the percentages of cells expressing each of the MHC class I1 molecules, or in their intensity of expression on unstimulated monocytes. In contrast, there was a significant reduction in both the percentage of cells expressing either HLA-DR and HLA-DP and in the intensity of expression of these molecules on IFN-g stimulated monocytes. There was also a significant reduction in both the percentage of cells expressing ICAM-1 and LFA-3 and in the intensity of their expression on both unstimulated and IFN-g stimulated monocytes. Figure 1 shows that there was a significant reduction in the antigen presenting function of monocytes following incubation in the presence of EPA+DHA and IFN-g.
These findings support the hypothesis that n-3 PUFAs may depress immune reactivity by suppressing the antigen-presenting function of monocytes via inhibition of the expression of monocyte surface molecules associated with this process. The suppression of MHC class I1 molecule and ICAM-1 expression observed in the presence of IFN-g supports the possibility that fish oil may be beneficial in the treatment of rheumatoid arthritis, a disorder associated with elevated expression of these molecules on synovial fluid monocytes [6] .
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